Jove
Visualize
Contact Us

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
The Central Dogma01:20

The Central Dogma

The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Recombinant DNA01:09

Recombinant DNA

Overview
Recombinant DNA01:09

Recombinant DNA

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gamification and serious games in dermatology education: A systematic review and quality assessment.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Natural and inducible regulatory B cells are widely distributed in ovine lymphoid tissues.

Veterinary immunology and immunopathology·2019
Same author

Standardization of dermoscopic terminology and basic dermoscopic parameters to evaluate in general dermatology (non-neoplastic dermatoses): an expert consensus on behalf of the International Dermoscopy Society.

The British journal of dermatology·2019
Same author

[Dermoscopy in special locations : Nails, acral skin, face, and mucosa].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2019
Same author

Dermoscopy and the diagnosis of primary cutaneous B-cell lymphoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Evidence for the existence of regulatory and effector B cell populations in Peyer's patches of sheep.

Veterinary immunology and immunopathology·2016
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 3, 2026

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

Veterinary DNA vaccines.

S van Drunen Littel-van den Hurk1, R P Braun, L A Babiuk

  • 1Veterinary Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

Methods in Molecular Medicine
|March 5, 2011
PubMed
Summary
This summary is machine-generated.

DNA vaccines offer a new, powerful approach to vaccine development. This technology aims to improve upon the safety of traditional vaccines while enhancing efficacy for a stronger immune response.

More Related Videos

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
11:00

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR

Published on: November 28, 2016

Related Experiment Videos

Last Updated: Jun 3, 2026

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
11:00

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR

Published on: November 28, 2016

Area of Science:

  • Vaccinology
  • Molecular Biology
  • Immunology

Background:

  • Traditional vaccine technologies include live, attenuated, inactivated, or subunit vaccines.
  • Live vaccines are efficacious but carry risks; inactivated/subunit vaccines are safer but may have limited efficacy or duration.
  • Existing vaccine methods face challenges in balancing safety, efficacy, and cost.

Purpose of the Study:

  • To introduce DNA vaccines as a novel technology for vaccine development.
  • To highlight the potential of DNA vaccines to overcome limitations of current vaccine approaches.
  • To position DNA vaccines as a promising alternative for generating protective immune responses.

Main Methods:

  • Exploration of DNA vaccine technology principles.
  • Comparison of DNA vaccines with existing vaccine platforms.
  • Assessment of potential advantages in antigen production.

Main Results:

  • DNA vaccines represent a new approach to subunit vaccine development.
  • This technology offers a potentially powerful method for generating antigenic material.
  • DNA vaccines aim to combine the safety of subunit vaccines with improved efficacy.

Conclusions:

  • DNA vaccines hold significant promise for future vaccine strategies.
  • This approach may offer a safer and more effective alternative to current vaccines.
  • Further development of DNA vaccines could revolutionize disease prevention.